Abstract:Tumor metastasis has become one of the great challenges of cancer diagnosis and effective treatment. Metastasis, a process is depicted that the primary tumor spread to distant organs or tissues to compose the new “citadel”. The circulating tumor cells which are escaping the immune surveillance can transfer to the host tumor and tissue. Once these adapt to the “host organ” microenvironment, composing the “metastatic tumor” with a strong multi-drug resistance. Therefore, curing the metastatic tumor hardly uses the traditional treatment independently. Nowadays, we focus on how to use the functional nanoparticles (NPs)to inhibit tumor metastasis effectively. One of treating metastasis issues is enriching the NPs in the tumor tissue. The EPR effect is the “navigator” of NPs. They can reach the tumor site effectively and tracing or inhibiting the metastatic tumor in possibility. Some research have found that the permeability factor such as nitric oxide contributed to the role of EPR effect in the tumor site, it improved the vascular permeability of the tumor site selectively, proved that NPs can be effectively delivered to the tumor site. Tumor tissues often show the specificity, which make the NPs target to the specific tumor tissue modifying the specific antibody. The NPs can be encapsulated by the homologous cancer cell membrane and release the anti-tumor drugs in the vicinity effectively, improving the treatment efficiency and the therapeutic effect obviously.. Nowadays, the CRISPR immune system develop a new gene editing technique. To delivery Cas-9 system in high efficiency, we can design a series of functional-nanoparticle delivery system. It is a kind of method which is safer than the virus vector and much more efficiency than the plasmid. In the meanwhile, it can grasp the relationship between the lack of gene function and phenotype of metastasis with controlling the tumor growth. Inhibition of CTCs in vivo circulation is the most indispensable step in preventing tumor metastasis, but it is hardly to capture circulating CTCs in the background of hundreds of millions of cells in the circulatory system effectively. In view of this problem, the researchers make use of NPs which can be modified. They can targeting and enriching the CTCs to inhibit the metastasis. We can predict that using NPs to develop microchips can capture and enrich CTCs in the blood circulation efficiently. Tumor “relapse” has been a clinical cure for cancer problem, especially malignant glioma which forms in the brain. Due to its good tumor tissue infiltration, it is hardly to remove the tumor completely by making surgery merely, and account for the secondary metastatic easily. Depending on the good targeting to tumor tissue, the magnetic nanoparticles(MNPs) can inhibit the expression of epidermal growth factor (EGFR) within the loaded-antibody. Moreover, they combine it with magnetic resonance imaging, locating the tumor accurately. It is improved that the MNPs inhibit the expression of EGFR and tumor recurrence and secondary metastasis potentially, indicating that the NPs have a great value with a long-distanced applying in clinic. In all, the review pays attention to the two aspects of metastases, including the inhibition of primary tumor invasion or metastasis and metastases proliferation or recurrence. Meanwhile, prospecting that the NPs can make great contributes to change the clinical treatment in the predicted future.

Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells

Micellar Nanoparticles Inhibit Breast Cancer and Pulmonary Metastasis by Modulating the Recruitment and Depletion of Myeloid-Derived Suppressor Cells.

Multifunctional Self-Delivery Micelles Targeting the Invasion-Metastasis Cascade for Enhanced Chemotherapy Against Melanoma and the Lung Metastasis

Sponge-like nano-system suppresses tumor recurrence and metastasis by restraining myeloid-derived suppressor cells-mediated immunosuppression and formation of pre-metastatic niche.

Enhanced Anti-Metastatic Therapy with Down-Regulation of Heparinase Expression by ROS-responsive Micellar Nanoparticles.

Targeted nanostrategies eliminate pre-metastatic niche of cancer

Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis.

Targeted Inhibition of Tumor Inflammation and Tumor-Platelet Crosstalk by Nanoparticle-Mediated Drug Delivery Mitigates Cancer Metastasis.

Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression

Progress of Nanoparticles Inhibiting Tumor Metastasis

Enhanced Melanoma-Targeted Therapy by "Fru-Blocked" Phenyboronic Acid-Modified Multiphase Antimetastatic Micellar Nanoparticles.

Specifically Eliminating Tumor-Associated Macrophages with an Extra- and Intracellular Stepwise-Responsive Nanocarrier for Inhibiting Metastasis.

Micellar Nanoparticles Inhibit the Postoperative Inflammation, Recurrence and Pulmonary Metastasis of 4T1 Breast Cancer by Blocking NF-κB Pathway and Promoting MDSCs Depletion.

Drug-Free Mesoporous Silica Nanoparticles Enable Suppression of Cancer Metastasis and Confer Survival Advantages to Mice with Tumor Xenografts

Multi-Site Attack, Neutrophil Membrane-Camouflaged Nanomedicine with High Drug Loading for Enhanced Cancer Therapy and Metastasis Inhibition.

Low Molecular Weight Heparin-Coated and Dendrimer-Based Core-Shell Nanoplatform with Enhanced Immune Activation and Multiple Anti-Metastatic Effects for Melanoma Treatment

Genetically engineered exosomes for targetedly preventing premetastatic niche formation and suppressing postoperative melanoma lung metastasis

Effective treatment of metastatic sentinel lymph nodes by dual-targeting melittin nanoparticles

Microfluidics analysis of cancer cell microenvironments and targeted destruction of cancer stem cells by nanomedicine

A Low-Molecular-weight Heparin-Coated Doxorubicin-Liposome for the Prevention of Melanoma Metastasis.

Effective treatment of the primary tumor and lymph node metastasis by polymeric micelles with variable particle sizes